0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Rubidomycin - A New Agent against Cancer (Paperback, Softcover reprint of the original 1st ed. 1969) Loot Price: R1,536
Discovery Miles 15 360
Rubidomycin - A New Agent against Cancer (Paperback, Softcover reprint of the original 1st ed. 1969): J. Bernard, R. Paul, M....

Rubidomycin - A New Agent against Cancer (Paperback, Softcover reprint of the original 1st ed. 1969)

J. Bernard, R. Paul, M. Boiron, C Jacquillat, R Maral

Series: Recent Results in Cancer Research, 20

 (sign in to rate)
Loot Price R1,536 Discovery Miles 15 360 | Repayment Terms: R144 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Trials in the treatment of the leukemias are sometimes based on a hypothesis, as in the case of exchange transfusion [33] or the use of antimetabolites [86]. Or they are conducted empirically as the results of chance observations, as in the case of the use of the nitrogen mustards, urethane, and the Vinca alkaloids. Or they lie between the two, aiming at making use of well established biological facts: examples are the use of ACTH, cortisone and, more recently, the antibiotics. What is true for bacteria may also perhaps be true, if not for elephants, at least for the malignant cells of mammals. It was this idea that lay behind the first attempts at treating cancer and leukemia with antibiotics. The results obtained by the use of certain substances extracted from micro-organisms (actinomycin, azaserine, mito mycin, rufocromomycin), although encouraging at times, were inconsistent. The action of rubidomycin appears to cover a wider spectrum and to be more consistent and more effective. As in the case of Homer and Christopher Columbus, the honor of having given birth to rubidomycin is claimed by more than one country and town. In fact, the same product was discovered in the same year, though quite independently, by a group of French workers [184] who described it under the name of rubidomycin, and by a group of Italian workers [87] who studied it under the name of daunomycin.

General

Imprint: Springer-Verlag
Country of origin: Germany
Series: Recent Results in Cancer Research, 20
Release date: July 2013
First published: July 2013
Editors: J. Bernard • R. Paul • M. Boiron • C Jacquillat • R Maral
Dimensions: 244 x 170 x 11mm (L x W x T)
Format: Paperback
Pages: 183
Edition: Softcover reprint of the original 1st ed. 1969
ISBN-13: 978-3-642-88127-5
Categories: Books > Medicine > Nursing & ancillary services > Pharmacy / dispensing
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-642-88127-0
Barcode: 9783642881275

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners